Skip to search formSkip to main contentSkip to account menu

Refractory Mycosis Fungoides

Known as: Mycosis Fungoides Refractory 
Mycosis fungoides resistant to treatment.
National Institutes of Health

Related topics

Related topics

17 relations
Atypical lymphocyteDermatopathic LymphadenopathyHematopoietic and Lymphoid CellHematopoietic and Lymphoid Tissue

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Outcomes for allogeneic stem cell transplantation in refractory mycosis fungoides and primary cutaneous gamma Delta T cell lymphomas
Abstract We report results on 23 patients with cutaneous T cell lymphoma (7 primary cutaneous γδ T cell lymphoma [PCGDT], 16… 
2019
2019
Impressive response of CD30‐negative, treatment‐refractory mycosis fungoides to brentuximab vedotin
Brentuximab vedotin is a CD30‐antibody/drug conjugate which has demonstrated excellent response in treating CD30‐positive mycosis… 
2017
2017
Allogeneic hematopoietic stem cell transplantation for refractory mycosis fungoides (MF) and Sezary syndrome (SS)
Cutaneous T cell lymphoma is a heterogeneous group of lymphoproliferative disorders with different clinical behavior and… 
Highly Cited
2016
Highly Cited
2016
Pembrolizumab for Treatment of Relapsed/Refractory Mycosis Fungoides and Sezary Syndrome: Clinical Efficacy in a Citn Multicenter Phase 2 Study
Background:PD-1 and PD-L1/PD-L2 are expressed by malignant T-cells in mycosis fungoides (MF) and Sezary syndrome (SS). PD-1 is… 
2011
2011
Multicenter phase II trial of enzastaurin in patients with relapsed or refractory advanced cutaneous T-cell lymphoma
This multicenter, single-arm, open-label non-randomized phase II trial (NCT00744991) was conducted in patients with recurrent… 
2011
2011
Role of radiation therapy in mycosis fungoides refractory to systemic therapy.
The long natural history of early stage mycosis fungoides (MF) makes its management a difficult problem. Skin lesions are… 
Highly Cited
2007
Highly Cited
2007
Defucosylated Anti–CC Chemokine Receptor 4 Monoclonal Antibody Combined with Immunomodulatory Cytokines: A Novel Immunotherapy for Aggressive/Refractory Mycosis Fungoides and Sézary Syndrome
Purpose: Sézary syndrome (SS) and Mycosis fungoides (MF) in the advanced stage have dismal prognoses. Because CC chemokine… 
2006
2006
Effective treatment of a case of refractory mycosis fungoides with imatinib
A 50-year-old man with a diagnosis of mycosis fungoides stage IIB (T3N0M0B0) was treated with topical corticosteroids, psoralens… 
2003
2003
Mycosis fungoides/Sézary syndrome
We report the use of Alemtuzumab (Campath-1H) as salvage treatment in three patients with advanced mycosis fungoides/Sézary… 
2002
2002
Granulomatous mycosis fungoides responsive to gemcitabine.
We report a 61-year-old woman with a 1-year-history of widespread erythematous scaly patches and plaques as well as red/purplish… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)